The aim of this study was to compare hemoglobin concentrations (SpHb, g/dL) measured via a point-of-care multi-wavelength pulse oximetry device to hemoglobin concentrations (Hb, g/dL) measured via a hematology analyzer among a group of SCD patients. This evidence concerns the gene GSTM1 and Schnyder corneal dystrophy.